中国现代药物应用2024,Vol.18Issue(1) :172-174.DOI:10.14164/j.cnki.cn11-5581/r.2024.01.045

阿托品联合其他干预措施在近视防控中的研究进展

Research progress of atropine combined with other interventions in the prevention and control of myopia

张毅 崔亚晨 闫瑾 李树茂
中国现代药物应用2024,Vol.18Issue(1) :172-174.DOI:10.14164/j.cnki.cn11-5581/r.2024.01.045

阿托品联合其他干预措施在近视防控中的研究进展

Research progress of atropine combined with other interventions in the prevention and control of myopia

张毅 1崔亚晨 1闫瑾 1李树茂1
扫码查看

作者信息

  • 1. 300041 天津市眼科医院
  • 折叠

摘要

本文综述了近视的发生发展机制和对应的治疗策略,重点阐述了应用阿托品联合其他干预措施治疗近视的作用机制及研究进展,并通过比较各种治疗方法的优缺点,提供更安全、有效的治疗方案,以便更好地推动近视治疗的发展.

Abstract

This paper reviews the occurrence and development mechanism of myopia and corresponding treatment strategies,focuses on the mechanism of action and research progress of the application of atropine combined with other intervention measures in the treatment of myopia,and provides a safer and more effective treatment plan by comparing the advantages and disadvantages of various treatment methods,so as to better promote the development of myopia treatment.

关键词

低浓度阿托品/联合干预/近视

Key words

Low concentration atropine/Concerted intervention/Myopia

引用本文复制引用

出版年

2024
中国现代药物应用
中国水利电力医学科学技术学会

中国现代药物应用

影响因子:0.862
ISSN:1673-9523
参考文献量15
段落导航相关论文